PPAR gamma agonists - plant compounds

PPAR gamma agonists - plant compounds

Автор: Moola A.K., Shobana G., Janani C.

Журнал: Журнал стресс-физиологии и биохимии @jspb

Статья в выпуске: 4 т.19, 2023 года.

Бесплатный доступ

The nuclear receptor peroxisome proliferator activated receptor-gamma (PPARg) controls adipocyte differentiation, as well as lipid metabolism and insulin sensitivity. As a result, PPARg is a promising candidate gene for a variety of human diseases, such as obesity and type 2 diabetes. Hyperglycemia associated with the metabolic syndrome and type 2 diabetes is treated with agonists of the nuclear receptor PPARg. The PPARg agonists of the thiazolidinedione type, despite being effective in normalizing blood glucose levels, have serious side effects, making the discovery of novel ligands extremely important . Natural products have historically proven to be a promising source of structures for drug development, and recent research has focused on the PPARg-activating potential of a wide range of natural products derived from traditionally used medicinal plants or dietary sources. This review highlights recent studies that have advanced our understanding of this receptor's role in metabolism, with a focus on the effects of compounds in the plant

Еще

Ppar gamma, type 2 diabetes, natural products

Короткий адрес: https://sciup.org/143180980

IDR: 143180980

Список литературы PPAR gamma agonists - plant compounds

  • Abahusian MA, Wright J, Dickerson JWT and Vol EB (1993) Retinol, a-tocopherol and carotenoids in diabetes. Eur J Clin Nutr 53, 630-635.
  • Agarwal, A.K. and Garg, A. (2002) A novel heterozygous mutation in peroxisome proliferator-activated receptor-y gene in a patient with familial partial lipodystrophy. Journal of Clinical Endocrinological Metabolism, 87, 408-411.
  • Ahad, A. Ganai, A. A. Mujeeb, M. and Siddiqui, W. A. (2014) Chrysin, an anti-inflammatory molecule, abrogates renal dysfunction in type 2 diabetic rats. Toxicology and Applied Pharmacology, 279, 1, 1-7,.
  • Ahad, A. Mujeeb, M. Ahsan, H. and Siddiqui W. A. (2014). Prophylactic effect of baicalein against renal dysfunction in type 2 diabetic rats. Biochimie, 106, 101-110.
  • Anonymous (2010) Regulators restrict Avandia in the US and suspend it in the EU. Nat Rev Drug Discov 9, 828-828.
  • Anuradha, C. V. (2013). Phytochemicals targeting genes relevant for type 2 diabetes. Canadian Journal of Physiology and Pharmacology, 91, 6, 397-411.
  • Ashby J, Brady A, Elcombe CR, Elliott BM, Ishmael J, Odum J, Tugwood JD, Kettle S, Purchase IF. (1994). Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum Exp Toxicol 13 Suppl 2: S1-117.
  • Atanasov A.G., Blunder M., Fakhrudin N., Liu X., Noha S.M., Malainer C. 2013. Polyacetylenes from Notopterygium incisum--new selective partial agonists of peroxisome proliferator-activated receptor-gamma. PLoS One. 8, e61755.
  • Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM (1999) PPARy is required for placental, cardiac, and adipose tissue development. Mol Cell 4, 585-595.
  • Bentley P, Calder I, Elcombe C, Grasso P, Stringer D, Wiegand HJ. (1993). Hepatic peroxisome proliferation in rodents and its significance for humans. Food Chem Toxicol 31, 857-907.
  • Berg JM, Tymoczko JL, Stryer L (2002). Biochemistry, 5th Ed. W. H. Freeman and Company, New York.
  • Braissant OL, Foufelle F, Scotto CH, Dau?a MI, Wahli WA. (1996) Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha,-beta, and-gamma in the adult rat. Endocrinology. 137(1), 354-66.
  • Chang, C. L. T. Lin, Y. Bartolome, A. P. Chen, Y. C. Chiu, S. C. and Yang, W. C. (2013) Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds. Evidence-based Complementary and Alternative Medicine. 2013, 1-33.
  • Chatterjee, V.K.K. (2000) Resistance to thyroid hormone, and peroxisome proliferator activated receptor y resistance. Biochemistry Society of Transactions, 29, 227-231.
  • Choi JH, Banks AS, Estall JL, Kajimura S, Boström P, Laznik D, Ruas JL, Chalmers MJ, Kamenecka TM, Blüher M, Griffin PR. (2010). Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARy by Cdk5. Nature. 466(7305), 451-6.
  • Choi JH, Banks AS, Kamenecka TM, Busby SA, Chalmers MJ, Kumar N, Kuruvilla DS, Shin Y, He Y, Bruning JB, Marciano DP. (2011) Antidiabetic actions of a non-agonist PPARy ligand blocking Cdk5-mediated phosphorylation. Nature. 477(7365), 477-81.
  • Choi, J. Yokozawa, T. and Oura, H. (1991). Improvement of hyperglycemia and hyperlipemia in streptozotocin-diabetic rats by a methanolic extract of Prunus davidiana stems and its main component, prunin. Planta Medica, 57, 3, 208- 211.
  • Choi S.S., Cha B.Y., Lee Y.S., Yonezawa T., Teruya T., Nagai K. (2009) Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells. Life Sci. 84, 908-914.
  • Christensen K.B., Petersen R.K., Kristiansen K., Christensen L.P. (2010) Identification of bioactive compounds from flowers of black elder (Sambucus nigra L.) that activate the human peroxisome proliferator-activated receptor (PPAR) gamma. Phytother Res. 24(Suppl 2), S129-S132.
  • Christensen K.B., Petersen R.K., Petersen S., Kristiansen K., Christensen L.P. (2009). Activation of PPARgamma by metabolites from the flowers of purple coneflower (Echinacea purpurea) J Nat Prod. 72, 933-937.
  • Christensen KB, Petersen RK, Petersen S, Kristiansen K, Christensen LP. (2009) Activation of PPARy by metabolites from the flowers of purple coneflower (Echinacea purpurea). Journal of natural products. 72(5), 933-937.
  • Coman C, Rugina OD, Socaciu C. (2012). Plants and natural compounds with antidiabetic action. Notulae Botanicae Horti Agrobotanici Cluj-Napoca. 40(1), 314-325.
  • Cornick C.L., Strongitharm B.H., Sassano G., Rawlins C., Mayes A.E., Joseph A.N. (2009). Identification of a novel agonist of peroxisome proliferator-activated receptors alpha and gamma that may contribute to the anti-diabetic activity of guggulipid in Lep(ob)/Lep(ob) mice. J Nutr Biochem. 20, 806-815.
  • Lowik C.W. (2003). Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein. J Biol Chem. 278, 962-967.
  • Do Q.T., Lamy C., Renimel I., Sauvan N., Andre P., Himbert F. (2007). Reverse pharmacognosy: identifying biological properties for plants by means of their molecule constituents: application to meranzin. Planta Medica. 73, 1235-1240.
  • Dutchak PA, Katafuchi T, Bookout AL, Choi JH, Ruth TY, Mangelsdorf DJ, Kliewer SA. (2012). Fibroblast growth factor-21 regulates PPARy activity and the antidiabetic actions of thiazolidinediones. Cell.
  • Baumgartner L., Markt P. (2010). Computer-aided discovery, validation, and mechanistic characterization of novel neolignan activators of peroxisome proliferator-activated receptor gamma. Mol Pharmacol. 77, 559-566.
  • Fiedorek, F.T., Wilson, G.G., Frith, L., Patel, J. & Abou-Donia, M. (2000) Monotherapy with G1262570, a tyrosine-based non-thiazolidinedione PPARy agonist, improves metabolic control in type 2 diabetes mellitus patients. Diabetes, 49 (Suppl. 1), Abstract 157-OR.
  • Garrett RH, Grisham CM (1997). Biochemistry, 2nd Ed. Harcourt Brace College Publishers, Orlando, Florida. Gothai, S. Ganesan, P. Park, S Y.. Fakurazi, S. Choi, D. K. and Arulselvan, P. (2016). Natural phyto-bioactive compounds for the treatment of type 2 diabetes: inflammation as a target. Nutrients,. 8. 8, 461.
  • Guan, Y. Hao, C. Cha D. R. (2005). Thiazolidinediones expand body fluid volume through PPAR/ stimulation of ENaC-mediated renal salt absorption. Nature Medicine, 11, 8, 861-866.
  • Guo, R. Liu, B. Wang, K. S. Zhou, W. Li, and Y. Xu, (2014). Resveratrol ameliorates diabetic vascular inflammation and macrophage infiltration in db/db mice by inhibiting the NF-kB pathway. Diabetes and Vascular Disease Research, 11, 2,. 92-102.
  • Guri AJ, Hontecillas R, Si H, Liu D, Bassaganya-Riera J (2007) Dietary abscisic acid ameliorates glucose tolerance and obesity-related inflammation in db/db mice fed high-fat diets. Clin Nutr 26, 107-116.
  • Han K.L., Jung M.H., Sohn J.H., Hwang J.K. (2006) Ginsenoside 20S-protopanaxatriol (PPT) activates peroxisome proliferator-activated receptor gamma (PPARgamma) in 3T3-L1 adipocytes. Biol Pharmaceut Bull. 29, 110-113.
  • Hegele, R.A., Henian, C., Frankowski, C., Mathews, S.T. & Leff, T. (2002) PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. Diabetes, 51, 3586-3590.
  • Hontecillas R, O'Shea M, Einerhand A, Diguardo M, Bassaganya-Riera J (2009) Activation of PPAR gamma and alpha by punicic acid ameliorates glucose tolerance and suppresses obesity-related inflammation. J Am Coll Nutr 28, 184-195.
  • Hotta M., Nakata R., Katsukawa M., Hori K., Takahashi S., Inoue H. (2010) Carvacrol, a component of thyme oil, activates PPARalpha and gamma and suppresses COX-2 expression. J Lipid Res. 51, 132139.
  • Huang TH, Kota BP, Razmovski V, Roufogalis BD (2005) Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome. Basic Clin Pharmacol 96, 3-14.
  • Hwang B.Y., Lee J.H., Nam J.B., Kim H.S., Hong Y.S., Lee J.J. (2002) Two new furanoditerpenes from Saururus chinenesis and their effects on the activation of peroxisome proliferator-activated receptor gamma. J Nat Prod. 65, 616-617.
  • Hwang, B. Y., J. H. Lee, J. B. Nam, H. S. Kim, Y. S. Hong & J. J. Lee: (2002). Two new furanoditerpenes Dang Z.C., Audinot V., Papapoulos S.E., Boutin J.A., Dat N.T., Lee K., Hong Y.S., Kim Y.H., Minh C.V., Lee J.J. 148(3), 556-567.
  • Fakhrudin N., Ladurner A., Atanasov A.G., Heiss E.H., Fang F., Kang Z., Wong C. (2010). Vitamin E tocotrienols from Saururus chinenesis and their effects on the activation of peroxisome proliferator-activated receptor gamma. J. Nat. Prod. , 65, 616- 617.
  • He Y.Q., Ma G.Y., Peng J.N., Ma Z.Y., Hamann M.T. (2012) Liver X receptor and peroxisome proliferator-activated receptor agonist from Cornus alternifolia. Biochim Biophys Acta. 1820, 1021-1026.
  • Kawada T. (2008) 6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-alpha mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 373, 429-434.
  • Issemann I, Green S. (1990). Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 347(6294), 645-50.
  • Janani C and Kumari BR. (2015). PPAR gamma gene-a review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 1;9(1), 46-50.
  • Janani C, and Kumari BR. (2017). Antidiabetic activity of methanolic leaves extracts of transformed soybean in 3T3-L1 preadipocytes cell line. Int J Pharm Sci Res. 1;8(11), 4732-4744.
  • Janani C, Sundararajan B, Kumari BR. (2019) Construction and transformation of peroxisome proliferator activated receptor gamma (RnPPARy) gene using Agrobacterium tumefaciens into Glycine max L. Merr. Gene Reports. 16, 100427.
  • Jaradat M.S., Noonan D.J., Wu B., Avery M.A., Feller D.R. (2002) Pseudolaric acid analogs as a new class of peroxisome proliferator-activated receptor agonists. Planta Medica. 68, 667-671.
  • Jayaprakasam B, Vareed SK, Olson LK and Nair MG (2005) Insulin secretion by bioactive anthocyanins and anthocyanidins present in fruits. J Agric Food Chem 53, 28-31.
  • Jonker JW, Suh JM, Atkins AR, Ahmadian M, Li P, Whyte J, He M, Juguilon H, Yin YQ, Phillips CT, Ruth TY. PS21-100. (2012). A PPAR-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis. Nederlands Tijdschrift voor Diabetologie. 10(3), 170-170.
  • Katsukawa M., Nakata R., Takizawa Y., Hori K., Takahashi S., Inoue H. (2010). Citral, a component of lemongrass oil, activates PPARalpha and gamma and suppresses COX-2 expression. Biochim Biophys Acta. 1801, 1214-1220.
  • Kim T., Lee W., Jeong K.H., Song J.H., Park S.H., Choi P. (2012) Total synthesis and dual PPARalpha/gamma agonist effects of amorphastilbol and its synthetic derivatives. Bioorg Med Chem Lett. 22, 4122-4126.
  • Kim, S. Shin, B. C. Lee, M. S. Lee, H. and Ernst, E. (2011) "Red ginseng for type 2 diabetes mellitus: a systematic review of randomized controlled trials," Chinese Journal of Integrative Medicine, 17. 12, 937944.
  • Kubota N et al. (1999) PPARy mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 4, 597-609.
  • Kumar, B. Gupta, S. K. Srinivasan B. P. (2013). Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats. Microvascular Research, 87, 65-74.
  • Kuroda M., Mimaki Y., Honda S., Tanaka H., Yokota S., Mae T. (2010). Phenolics from Glycyrrhiza glabra roots and their PPAR-gamma ligand-binding activity. Bioorg Med Chem. 18, 962-970.
  • Kuroda, M., Y. Mimaki, Y. Sashida, T. Mae, H. Kishida, T. Nishiyama, M. Tsukagawa, E. Konishi, K. Takahashi, T. Kawada, K. Nakagawa M. (2003). Kitahara: Phenolics with PPAR-gamma ligand-binding activity obtained from licorice (Glycyrrhiza uralensis roots) and ameliorative effects of glycyrin on genetically diabetic KK-A(y) mice. Bioorg. Med. Chem. Lett. 13, 4267- 4272.
  • Lee, C. H., Olson P., Evans R. M. (2003). Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator activated receptors. Endocrinology, 144, 2201- 2207.
  • Li, J. J. Lee, S. H. Kim D. K. (2009). Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy. American Journal of Physiology-Renal Physiology, 297, 1, F200-F209,.
  • Liang, Y. C., Tsai S. H., Tsai D. C., Lin Shiau S. Y., Lin J. Isa Y., Miyakawa Y., Yanagisawa M., Goto T., Kang M.S., K. (2001). Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator activated receptor gamma by flavonoids in mouse macrophages. FEBS Lett., 496, 12- 18.
  • Matsuda H, Kogami Y, Nakamura S, Sugiyama T, Ueno T, Yoshikawa M. (2011) Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells. Bioorg. Med. Chem., 19, 2835-2841.
  • Metibemu DS, Akinloye OA, Akinbamiwa BA, et al. (2017) Austroinulin from Stevia rebaudiana a Potential Agonist of the Peroxisome Proliferator-activated Receptor (PPARy): an in-silico Study. J Syst Biol Proteome Res., 1(1), 10-15
  • Miles, P.D., Barak, Y., He, W., Evans, R.M. & Olefsky, J.M. (2000) Improved insulin-sensitivity in mice heterozygous for PPARy deficiency. Journal of Clinical Investigations, 105, 287-292.
  • Mlinar B, Marc J, Janez A, Pfeifer M (2007). Molecular mechanisms of insulin resistance and associated diseases. Clin Chim Acta 375:20-35
  • Moskaug JO, Carlsen H, Myhrstad M & Blomhoff R (2004) Molecular imaging of the biological effects of quercetin and quercetin-rich foods. Mech Ageing Dev 125, 315-324.
  • Mourad AA, Nakamura S, Ueno T, Minami T, Yagi T, Yasue H, Komatsu R, Yoshikawa M, Taye AM, El-Moselhy MA, Khalifa MM, Matsuda H. (2013). Adipogenetic effects of retrofractamide A derivatives in 3T3-L1 cells. Bioorg. Med. Chem. Lett., 23, 4813-
  • A.R., Jungbauer A. (2008). Oregano: a source for peroxisome proliferator-activated receptor gamma antagonists. J Agr Food Chem. 56, 11621-11630.
  • Mukherjee, R., Davies, P.J.A., Crombie, D.L., Dischoff, E.D., Cesario, R.M., Jow, L., Hamann, L.G., Mondon, C.E., Nadzan, A.M., Paterniti, J.J.R. & Heyman, R.A. (1997) Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature, 386,
  • Minh C.V. (2012). Inhibition of nuclear transcription factor-kappaB and activation of peroxisome proliferator-activated receptors in HepG2 cells by cucurbitane-type triterpene glycosides from Momordica charantia. J Med Food. 15, 369-377.
  • Ntambi JM, Young-Cheul K. (2000) Adipocyte differentiation and gene expression. The Journal of nutrition. 130(12), 3122S-6S.
  • Ohno, M. Shibata, C. Kishikawa T. (2013). The flavonoid apigenin improves glucose tolerance through inhibition of microRNA maturation in miRNA103 transgenic mice. Scientific Reports, 3, 1, 2013.
  • O'Sullivan S.E., Tarling E.J., Bennett A.J., Kendall D.A., Randall M.D. (2005). Novel time-dependent vascular actions of Delta9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma. Biochem Biophys Res Commun. 337, 824831.
  • Park H.G., Bak E.J., Woo G.H., Kim J.M. , Quan Z., Yoon H.K. (2012). Licochalcone E has an antidiabetic effect. J Nutr Biochem. 23, 759-767.
  • Petersen R.K., Christensen K.B., Assimopoulou A.N., Frette X., Papageorgiou V.P., Kristiansen K. (2011) Pharmacophore-driven identification of PPARgamma agonists from natural sources. J Comput-Aid Mol Des. 25, 107-116.
  • Pferschy-Wenzig E.M., Atanasov A.G., Malainer C., Noha S.M., Kunert O., Schuster D. (2014) Identification of isosilybin a from milk thistle seeds as an agonist of peroxisome proliferator-activated receptor gamma. J Nat Prod. 77, 842-847.
  • Prabhakar, O. (2013) Cerebroprotective effect of resveratrol through antioxidant and anti-inflammatory effects in diabetic rats. Naunyn-Schmiedeberg's Archives of Pharmacology, 386, 8, 705-710.
  • Priya RM, Padmakumari KP, Sankarikutty B, Lijo Cherian O, Nisha VM, Raghu KG. (2011). Inhibitory potential of ginger extracts against enzymes linked to type 2 diabetes, inflammation and induced oxidative stress. International Journal of Food Sciences and Nutrition. 62(2), 106-110.
  • Rau O., Wurglics M., Paulke A., Zitzkowski J., Meindl N., Bock A. (2006) Carnosic acid and carnosol, phenolic diterpene compounds of the labiate herbs rosemary 4816.
  • Mueller M., Lukas B., Novak J., Simoncini T., Genazzani 407-410.
  • Nhiem N.X., Yen P.H., Ngan N.T., Quang T.H., Kiem P.V., and sage, are activators of the human peroxisome proliferator-activated receptor gamma. Planta Medica. 72, 881-887.
  • Rocchi, S., Picard, F., Vamecq, J., Gelman, L., Potier, N., Zeyer, D., Dubuquoy, L., Bac, P., Champy, M.-F., Plunket, K.D., Leesnitzer, L.M., Blanchard, S.G., Desreumaux, P., Moras, D., Renaud, J.-P. & Auwerx, J. (2001) A unique PPARy ligand with potent insulin-sensitising yet weak adipogenic activity. Molecular Cell, 8, 737-747.
  • Rosen CJ (2010) Revisiting the rosiglitazone story-lessons learned. N Engl J Med 363, 803-806
  • Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM (1999) PPARy is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4, 611-
  • Tanaka K. (2002) Dehydrotrametenolic acid induces preadipocyte differentiation and sensitizes animal models of noninsulin-dependent diabetes mellitus to insulin. Biol Pharmaceut Bull. 25, 81-86.
  • Sato, M., Tai T., Nunoura Y., Yajima Y., Kawashima S. & Tanaka K. (2002). Dehydrotrametenolic acid induces preadipocyte differentiation and sensitizes animal models of noninsulin- dependent diabetes mellitus to insulin. Biol. Pharm. Bull., 25, 81- 86.
  • Schoonjans K, Auwerx J. (2000). Thiazolidinediones: an update. The Lancet. 355(9208), 1008-1010.
  • Sesti G (2006). Pathophysiology of insulin resistance. Beat Pract Res Clin Endocrinol Metab 20, 665-679.
  • Shen P., Liu M.H., Ng T.Y., Chan Y.H., Yong E.L. (2006). Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the activation of PPARalpha, PPARgamma, and adipocyte differentiation in vitro. J Nutr. 136, 899905.
  • Shin D.W., Kim S.N., Lee S.M., Lee W., Song M.J., Park S.M. 2009 (-)-Catechin promotes adipocyte differentiation in human bone marrow mesenchymal stem cells through PPAR gamma
  • Soumyanath A (2006). Traditional Medicines for Modern Times - Antidiabetic Plants, Ed. CRC Press, Boca Raton, London, New York.
  • Takahashi N., Goto T., Taimatsu A., Egawa K., Katoh S., Kusudo T. (2009). Bixin regulates mRNA expression involved in adipogenesis and enhances insulin sensitivity in 3T3-L1 adipocytes through PPARgamma activation. Biochem Biophys Res Commun. 390, 1372-1376.
  • Tantry M.A., Dar J.A., Idris A., Akbar S., Shawl A.S. (2012). Acylated flavonol glycosides from Epimedium elatum, a plant endemic to the Western Himalayas. Fitoterapia. 83, 665-670.
  • Tontonoz P, Hu E, Spiegelman BM. (1995) Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor y. Current opinion in genetics & development. 5(5), 571-576.
  • Tsai, S.-J. Huang, C.-S. Mong, M.-C. Kam, W.-Y. Huang, H.-Y. and Yin, M.-C. (2012) Anti-inflammatory and antifibrotic effects of naringenin in diabetic mice. Journal of Agricultural and Food Chemistry, 60, 1, 514-521,.
  • Tsuda T, Ueno Y, Yoshikawa T, Kojo H & Osawa T (2006). Microarray profiling of gene expression in human adipocytes in response to anthocyanins. Biochem Pharmacol 71, 1184-1197.
  • Unuofin J. O., Otunola, GA. and Afolayan, A. J. (2018) In vitro a-amylase, a-glucosidase, lipase inhibitory and cytotoxic activities of tuber extracts of Kedrostis africana (L.) Cogn. Heliyon. 4, 9, e00810,.
  • Unuofin JO, Lebelo SL. (2020). Antioxidant effects and mechanisms of medicinal plants and their bioactive compounds for the prevention and treatment of type 2 diabetes: an updated review. Oxidative medicine and cellular longevity. 13; 1-36.
  • Watkins PB, Whitcomb RW. (1998). Hepatic dysfunction associated with troglitazone. New England Journal of Medicine. 338(13), 916-917.
  • Weidner C., de Groot J.C., Prasad A., Freiwald A., Quedenau C., Kliem M. (2012). Amorfrutins are potent antidiabetic dietary natural products. Proc Natl 617.
  • Sato M., Tai T., Nunoura Y., Yajima Y., Kawashima S., transactivation. Biochem Pharmacol. 77, 125-133. Acad Sci USA. 109, 7257-7262.
  • Weidner C., de Groot J.C., Prasad A., Freiwald A., Quedenau C., Kliem M. (2012). Amorfrutins are potent antidiabetic dietary natural products. Proc Natl Acad Sci USA. 109, 7257-7262.
  • Willson TM, Brown PJ, Sternbach DD, Henke BR. (2000). The PPARs: from orphan receptors to drug discovery. Journal of medicinal chemistry. 43(4), 52750.
  • Yamauchi, T., Kamon, J., Waki, H., Murakami, K., Motojima, K., Komeda, K., Ide, T., Kubota, N., Terauchi, Y., Tobe, K., Miki, H., Tsuchida, A., Akanuma, Y., Nagai, R., Kimura, S. & Kadowaki, T. (2001) The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARy) deficiency and PPARy agonist improve insulin resistance. Journal of Biological Chemistry, 276, 41245-41254
  • Yang M.H., Vasquez Y., Ali Z., Khan I.A., Khan S.I. (2013) Constituents from Terminalia species increase PPARalpha and PPARgamma levels and stimulate glucose uptake without enhancing adipocyte differentiation. J Ethnopharmacol. 149, 490-498.
  • Yang, L.-P. Sun, H.-l. Wu L.-M. (2009). Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy. Investigative Opthalmology & Visual Science, 50(5), 2319.
  • Yokoi H., Mizukami H., Nagatsu A., Ohno T., Tanabe H., Inoue M. (2009) Peroxisome proliferator-activated receptor gamma ligands isolated from adlay seed (Coix lacryma-jobi L. var. ma-yuen STAPF.) Biol Pharmaceut Bull. 32, 735-740.
  • Zhang H, Matsuda H, Yamashita C, Nakamura S, Yoshikawa M. (2009) Hydrangeic acid from the processed leaves of Hydrangea macrophylla var. thunbergii as a new type of anti-diabetic compound.Eur J Pharmacol. 606(1-3), 255-61.
  • Zhu Y, Alvares K, Huang Q, Rao MS, Reddy JK. (1993). Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. Journal of Biological Chemistry. 268(36), 26817-26820.
  • Zoechling A, Liebner F, Jungbauer A. (2011). Red wine: a source of potent ligands for peroxisome proliferator-activated receptor y. Food & function., 2(1), 28-38.
  • Zoechling A., Liebner F., Jungbauer A. (2011) Red wine: a source of potent ligands for peroxisome proliferator-activated receptor gamma. Food Funct. 2, 28-38.
  • Zou G., Gao Z., Wang J., Zhang Y., Ding H., Huang J. (2008) Deoxyelephantopin inhibits cancer cell proliferation and functions as a selective partial agonist against PPARgamma. Biochem Pharmacol. 75, 1381-1392.
Еще
Статья обзорная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp